» Articles » PMID: 8807064

Identification for Mar Mutants Among Quinolone-resistant Clinical Isolates of Escherichia Coli

Overview
Specialty Pharmacology
Date 1996 Jul 1
PMID 8807064
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Quinolone-resistant clinical Escherichia coli isolates were examined for mutations in the marRAB operon of the multiple antibiotic resistance (mar) locus. Among 23 strains evaluated, 8 were chosen for further study: 3 that showed relatively high levels of uninduced, i.e., constitutive, expression of the operon and 5 with variable responses to induction by salicylate or tetracyclines. The marR genes, specifying the repressor of the operon, cloned from the three strains constitutively expressing the operon did not reduce the level of expression of beta-galactosidase from a marO::lacZ transcriptional fusion and were therefore mutant; however, marR genes cloned from the five other clinical strains repressed LacZ expression and were wild type. All three mutant marR genes contained more than one mutation: a deletion and a point mutation. Inactivation of the mar locus in the three known marR mutant strains with a kanamycin resistance cassette introduced by homologous recombination reduced resistance to quinolones and multiple antibiotics. These findings indicate that mar operon mutations exist in quinolone-resistant clinical E. coli isolates and contribute to quinolone and multidrug resistance.

Citing Articles

First report of coexistence of blaKPC-2 and blaNDM-1 in carbapenem-resistant clinical isolates of in Brazil.

Rodrigues S, Nunes G, Soares G, Ferreira R, Damas M, Laprega P Front Microbiol. 2024; 15:1352851.

PMID: 38426065 PMC: 10903355. DOI: 10.3389/fmicb.2024.1352851.


Chance Favors the Prepared Genomes: Horizontal Transfer Shapes the Emergence of Antibiotic Resistance Mutations in Core Genes.

Coluzzi C, Guillemet M, Mazzamurro F, Touchon M, Godfroid M, Achaz G Mol Biol Evol. 2023; 40(10).

PMID: 37788575 PMC: 10575684. DOI: 10.1093/molbev/msad217.


Understanding Functional Redundancy and Promiscuity of Multidrug Transporters in under Lipophilic Cation Stress.

Radi M, Munro L, Salcedo-Sora J, Kim S, Feist A, Kell D Membranes (Basel). 2022; 12(12).

PMID: 36557171 PMC: 9783932. DOI: 10.3390/membranes12121264.


TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli.

Ou J, Elizalde P, Guo H, Qin H, Tobe B, Choy J mBio. 2022; 13(6):e0219122.

PMID: 36374097 PMC: 9765716. DOI: 10.1128/mbio.02191-22.


Emergence of Resistant Mutants in Microfluidic Antibiotic Gradients.

Nagy K, Dukic B, Hodula O, Abraham A, Csakvari E, Der L Front Microbiol. 2022; 13:820738.

PMID: 35391738 PMC: 8981919. DOI: 10.3389/fmicb.2022.820738.


References
1.
George A, Levy S . Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol. 1983; 155(2):531-40. PMC: 217720. DOI: 10.1128/jb.155.2.531-540.1983. View

2.
Goldman J, White D, Levy S . Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother. 1996; 40(5):1266-9. PMC: 163305. DOI: 10.1128/AAC.40.5.1266. View

3.
Wolfson J, Hooper D . The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother. 1985; 28(4):581-6. PMC: 180310. DOI: 10.1128/AAC.28.4.581. View

4.
Beji A, Izard D, Gavini F, Leclerc H, KREMBEL J . A rapid chemical procedure for isolation and purification of chromosomal DNA from gram-negative bacilli. Anal Biochem. 1987; 162(1):18-23. DOI: 10.1016/0003-2697(87)90005-4. View

5.
Aoyama H, Sato K, Kato T, Hirai K, Mitsuhashi S . Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 1987; 31(10):1640-1. PMC: 175005. DOI: 10.1128/AAC.31.10.1640. View